New appointment at Elan
This article was originally published in Scrip
Elanhas named Dr Carlos Paya president. He will be based at the company's South San Francisco campus, where he will be responsible for leading the company's scientific, clinical and medical initiatives. Dr Paya joins from Lilly, where he served as vice-president of Lilly Research Laboratories and global leader of the diabetes and endocrine platform.